Skip to main content

Advertisement

Log in

Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells

  • Review
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Foamy viruses (FVs) are classified to a subfamily of retrovirus presented in a wide range of hosts. None of FVs has been found to associate with any diseases in their native hosts. Such a unique biological character of FVs makes it suitable for the development of vectors for gene transfer. However, it is still controversial whether foamy virus vectors (FV vectors) can be applied to the central nervous system (CNS). In this review, we summarize the studies of FV vectors, which have been used for transduction of neural cells and other nondividing cells. We further discuss the potential mechanisms underlying the infection and propose that FVs can be used to develop transfer vectors for gene therapy in neurological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Achong BG, Mansell PW, Epstein MA, Clifford P (1971). An unusual virus in cultures from a human nasopharyngeal carcinoma.J Natl Cancer Inst 46: 299–307.

    CAS  PubMed  Google Scholar 

  • Bauer TR Jr, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, Adler RL, Burkholder TH, Gu YC, Russe DW, Hickstein DD (2008). Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.Nat Med 14: 93–97.

    Article  CAS  PubMed  Google Scholar 

  • Blau H, Khavari P (1997). Gene therapy, progress, problems, prospects.Nat Med 3: 612–613.

    Article  CAS  PubMed  Google Scholar 

  • Campbell M, Eng C, Luciw PA (1996). The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene.J Virol 70: 6847–6855.

    CAS  PubMed  Google Scholar 

  • Caprariello AV, Miller RH, Selkirk SM (2009). Foamy virus as a gene transfer vector to the central nervous system.Gene Ther 16: 448–452.

    Article  CAS  PubMed  Google Scholar 

  • Delelis O, Lehmann-Che J, Saïb A (2004). Foamy viruses—a world apart.Curr Opin Microbiol 7: 400–406.

    Article  CAS  PubMed  Google Scholar 

  • Enssle J, Jordan I, Mauer B, Rethwilm A (1996). Foamy virus reverse transcriptase is expressed independently from the Gag protein.Proc Natl Acad Sci U S A 93: 4137–4141.

    Article  CAS  PubMed  Google Scholar 

  • Flugel RM, Rethwilm A, Maurer B, Darai G (1987). Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveal two novel genes.EMBO J 6: 2077–2084.

    CAS  PubMed  Google Scholar 

  • Flugel RM, Spumaviruses (1991). A group of complex retrovirus.J Acquir Immune Defic Syndr 4: 739–750.

    CAS  PubMed  Google Scholar 

  • Glorioso JC, Mata M, Fink DJ (2003). Therapeutic gene transfer to the nervous system using viral vectors.J NeuroVirol 9: 165–172.

    CAS  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, Kalle CV, Schmidt M, Deist FL, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.N Engl J Med 348: 255–256.

    Article  PubMed  Google Scholar 

  • Heneine W, Switzer WM, Sandstrom P, Brown J, Vedapuri S, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks TM (1998). Identification of a human population infected with simian foamy viruses.Nat Med 4: 403–407.

    Article  CAS  PubMed  Google Scholar 

  • Josephson NC, Trobridge G, Russell DW (2004). Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors.Hum Gene Ther 15: 87–92.

    Article  CAS  PubMed  Google Scholar 

  • Khan AS (2009). Simian foamy virus infection in humans: prevalence and management.Expert Rev Anti Infect Ther 7: 569–580.

    Article  CAS  PubMed  Google Scholar 

  • Linial M (2000). Why aren’t foamy viruses pathogenic?Trends Microbiol 8: 284–289.

    Article  CAS  PubMed  Google Scholar 

  • Lewis PF, Emerman M (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.J Virol 68: 510–516.

    CAS  PubMed  Google Scholar 

  • Liu W, He X, Cao Z, Sheng J, Liu H, Li Z, Li W (2005). Efficient therapeutic gene expression in cultured rat hippocampal neurons mediated by human foamy virus vectors: a potential for the treatment of neurological diseases.Intervirology 48: 329–335.

    Article  CAS  PubMed  Google Scholar 

  • Liu W, Liu Z, Cao X, Cao Z, Xue L, Zhu F, He X, Li W (2007). Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes.Mol Ther 15: 1834–1841.

    Article  CAS  PubMed  Google Scholar 

  • Liu W, Liu Z, Liu L, Xiao Z, Cao X, Cao Z, Xue L, Miao L, He X, Li W (2008). A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury.Neurosci Lett 432: 13–18.

    CAS  PubMed  Google Scholar 

  • Lochelt M, Muranyi W, Flugel RM (1993). Human foamy virus genome possesses an internal Bel-1-dependent and functional promoter.Proc Natl Acad Sci U S A 90: 7317–7321.

    Article  CAS  PubMed  Google Scholar 

  • Löchelt M, Yu SF, Linial ML, Flügel RM (1995). The human foamy virus internal promoter is required for efficient gene expression and infectivity.Virology 206: 601–610.

    Article  PubMed  Google Scholar 

  • Lo YT, Tian T, Nadeau PE, Park J, Mergia A (2010). The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.J Virol 84: 2832–2842.

    Article  CAS  PubMed  Google Scholar 

  • Lundberg C, Horellou P, Mallet J, Bjorklund A (1996). Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model.Exp Neurol 139: 39–53.

    Article  CAS  PubMed  Google Scholar 

  • Marchand F, Jones NG, McMahon SB (2009). Future treatment strategies for neuropathic pain.Handb Exp Pharmacol 194: 589–615.

    Article  CAS  PubMed  Google Scholar 

  • Marshall E (2002). Gene therapy a suspect in leukemia-like disease.Science 298: 34–35.

    Article  CAS  PubMed  Google Scholar 

  • Marshall E (2003). Gene therapy. Second child in French trial is found to have leukemia.Science 299: 320.

    Article  CAS  PubMed  Google Scholar 

  • Maurer B, Bannert H, Darai G, Flugel RM (1988). Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus.J Virol 62: 1590–1597.

    CAS  PubMed  Google Scholar 

  • Meiering CD, Linial ML (2001). Historical perspective of foamy virus epidemiology and infection.Clin Microbiol Rev 14: 165–176.

    Article  CAS  PubMed  Google Scholar 

  • Meredith A, Mintzer, Simanek EE (2009). Nonviral vectors for gene delivery.Chem Res 109: 259–302.

    Google Scholar 

  • Mergia A, Chari S, Kolson DL, Goodenow MM, Ciccarone T (2001). The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.Virology 280: 243–252.

    Article  CAS  PubMed  Google Scholar 

  • Miller AD, Miller DG, Garcia JV, Lynch CM (1993). Use of retroviral vectors for gene transfer and expression.Methods Enzymol 217: 581–599.

    Article  CAS  PubMed  Google Scholar 

  • Moebes A, Enssle J, Bieniasz PD, Heinkelein M, Lindemann D, Bock M, McClure MO, Rethwilm A (1997). Human foamy virus reverse transcription that occurs late in the viral replication cycle.J Virol 71: 7305–7311.

    CAS  PubMed  Google Scholar 

  • Morozov VA, Copeland TD, Nagashima K, Gonda MA, Oroszlan S (1997). Protein composition and morphology of human foamy virus intracellular cores and extracellular particles.Virology 228: 307–317.

    Article  CAS  PubMed  Google Scholar 

  • Patton GS, Morris SA, Chung W, Bieniasz PD, McClure MO (2005). Identification of domains in gag important for prototypic foamy virus egress.J Virol 79: 6392–6399.

    Article  CAS  PubMed  Google Scholar 

  • Picard-Maureau M, Kreppel F, Lindemann D, Juretzek T, Herchenröder O, Rethwilm A, Kochanek S, Heinkelein M (2004). Foamy virus-adenovirus hybrid vectors.Gene Therapy 11: 722–728.

    Article  CAS  PubMed  Google Scholar 

  • Rethwilm A (2007). Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.Curr Gene 7: 261–271.

    Article  CAS  Google Scholar 

  • Ridet JL, Sarkis C, Serguera C, Zennou V, Charneau P, Mallet J (2003). Transplantation of human adult astrocytes: efficiency and safety requirements for an autologous gene therapy.J Neurosci Res 72: 704–708.

    Article  CAS  PubMed  Google Scholar 

  • Roe T, Reynolds TG, Yu G, Brown PO (1993). Intergration of murine leukemia virus DNA depends on mitosis.EMBO J 12: 2099–2108.

    CAS  PubMed  Google Scholar 

  • Russell DW, Miller AD (1996). Foamy virus vectors.J Virol 70: 217–222.

    CAS  PubMed  Google Scholar 

  • Saïb A, Puvion-Dutilleul F, Schmid M, Périès J, de Thé H (1997). Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step.J Virol 71: 1155–1161.

    PubMed  Google Scholar 

  • Schiephake AW, Rethwilm A (1994). Nuclear localization of foamy virus gag precursor protein.J Virol 68: 4946–4954.

    Google Scholar 

  • Schweizer M, Falcone V, Gange J, Turek R, Neumann-Haefelin D (1997). Simian foamy virus isolated from an accidentally infected human individual.J Virol 71: 4821–4824.

    CAS  PubMed  Google Scholar 

  • Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995). Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans.AIDS Res Hum Retroviruses 11: 161–170.

    Article  CAS  PubMed  Google Scholar 

  • Shi N, Pardridge WM (2000). Noninvasive gene targeting to the brain.Proc Natl Acad Sci U S A 97: 7567–7572.

    Article  CAS  PubMed  Google Scholar 

  • Snyder EY, Senut MC (1997). The use of nonneuronal cells for gene delivery.Neurobiol Dis 4: 69–102.

    Article  CAS  PubMed  Google Scholar 

  • Suzuki Y, Craigie R (2007). The road to chromatin: nuclear entry of retroviruses.Nat Rev Microbiol 5: 187–196.

    Article  CAS  PubMed  Google Scholar 

  • Trobridge G, Josephson N, Vassilopoulos G, Mac J, Russell DW (2002). Improved foamy virus vectors with minimal viral sequences.Mol Ther 6: 321–328.

    Article  CAS  PubMed  Google Scholar 

  • Trobridge G, Russell DW (2004). Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.J Virol 78: 2327–2335.

    Article  CAS  PubMed  Google Scholar 

  • Trobridge GD (2009). Foamy virus vectors for gene transfer.Expert Opin Biol Ther 9: 1427–1436.

    Article  CAS  PubMed  Google Scholar 

  • Verma IM, Somia N (1997). Gene therapy.Nature 389: 239–242.

    Article  CAS  PubMed  Google Scholar 

  • Vile RG, Rusell SJ (1995). Retroviruses as vectors.Br Med Bull 51: 12–30.

    CAS  PubMed  Google Scholar 

  • Weiss RA (1988) Foamy retroviruses. A virus in search of a disease.Nature 333: 497–498.

    Article  CAS  PubMed  Google Scholar 

  • Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, Tamoufe U, Prosser AT, Torimiro JN, Wright A, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Heneine W (2004). Naturally acquired simian retrovirus infections in central African hunters.Lancet 363: 932–937.

    Article  PubMed  Google Scholar 

  • Yu SF, Baldwin DN, Gwynn WR, Yendapalli S, Linial ML (1996a). Human foamy virus replication: a pathway distinct from that of retrovirus and hepadnaviruses.Science 271: 1579–1582.

    Article  CAS  PubMed  Google Scholar 

  • Yu SF, Edelman K, Strong RK, Moebes A, Linial ML (1996b). The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domain.J Virol 70: 8255–8262.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Wanhong Liu or Xiaohua He.

Additional information

This paper was first published online on Early Online on 23 October 2010.

Yingying Zhang and Yongjuan Liu made equal contribution to this work. This work was supported by National Natural Sciences Foundation of China (No. 30870856 and 30970145), Program for New Century Excellent Talents in Wuhan University by the Ministry of Education of China (No. NCET-07-0630), the Scientific Research Foundation for the Returned Overseas Scholars by the Ministry of Education of China, Research Fund for the Doctoral Program of Higher Education of China (No. 20090141110010), and the Independent Scientific Research Foundation of Wuhan University (No.3081002). The authors acknowledge the critical reading and editing by Dr. Yingqun Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Y., Liu, Y., Zhu, G. et al. Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells. Journal of NeuroVirology 16, 419–426 (2010). https://doi.org/10.1007/BF03210847

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03210847

Keywords

Navigation